It was only a single bullet in his pocket while waiting to board an airplane. But St. Jude Medical CEO Daniel Starks is in a different league, one often inhabited by professional athletes and celebrities rather than medical technology executives, after his detention last week at a Delhi, India airport.
Among the life science current events from last week: Daniel Starks' India arrest, Android v. iPad in healthcare, autism software looks to help schools, Medtronic's offshoring plan, and reimbursements in diabetes.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
St. Jude Medical’s (NYSE:STJ) chief executive officer Daniel Starks was free to travel inside India on Thursday, a day after authorities detained him for having a single round of live ammunition on him at the Delhi airport.
St. Jude Medical’s (NYSE:STJ) chief executive officer was arrested in India on Wednesday after authorities at the Delhi airport found a single live round tucked into a knee pocket of his cargo pants, according to media reports. Daniel Starks was in India on business and was about to take a chartered flight from the Indira […]
Earnings reports are good ways to measure a company's financial performance. What they're less useful for is gauging a company's confidence. You know... Mojo. Swagger. Groove. And here's what I see: Medtronic Inc. (NYSE:MDT) always had it. Boston Scientific Corp. (NYSE:BSX) has lost it. And St. Jude Medical Inc. (NYSE: STJ) is feeling it.
St. Jude Medical Inc. (NYSE:STJ) on Tuesday upgraded its end-of-the-year profit forecast after reporting a third quarter adjusted earnings gain of 16.5 percent. The medical device maker, based in Little Canada, Minnesota, said it now expects to make $2.98 to $3.00 a share, compared to its earlier estimate of $2.78 to $2.83 a share.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
St. Jude Medical Inc. (NYSE: STJ) said Monday it will acquire fellow Minnesota medical device maker AGA Medical Holdings Inc. (NASDAQ:AGAM) for $1.3 billion. Under terms of the all-cash agreement, St. Jude, based in Little Canada, will pay $20.80 for each share of AGA stock and assume $225 million in AGA debt. The company expects to close the deal by the end of the year.
Medtronic's earnings are bad news for the medical device industry and may indicate the global economy is in worse shape than people think.
A Minnesota judge hearing a dispute between Medtronic Inc. (NYSE:MDT) and St. Jude Medical Inc. (NYSE: STJ) over the hiring of a top executive has split the difference. Joseph McCullough can start work at Medtronic in November, not May 2011, as St. Jude had wanted, according to a ruling by Ramsey District Court Judge M. […]
In Minnesota, the sincerest form of flattery is not imitation but rather working for the enemy. According to the Star Tribune in Minneapolis, St. Jude Medical Inc. (NYSE: STJ) filed a lawsuit against a former top executive, accusing the man of violating a non-compete agreement. The company fears the man will share confidential information with […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
It’s been a while since we could get excited about implantable cardioverter defibrillators (ICDs), the watch-sized devices that shock an irregular heart back into rhythm. The device that helped launched the dominance of Minnesota’s medical device industry barely registers a yawn today. ICDs are what we call a “mature” industry, growing around 4 to 6 […]
Normally, you wouldn’t expect the CEO of a major medical device company to employ the phrase “absolutely awesome” during a conference call with Wall Street analysts. But then again, you really can’t blame St. Jude Medical Inc. (NYSE: STJ) CEO Dan Starks for showing a little enthusiasm. Starks was specifically referring to the initial sales […]